85 Participants Needed

Insulin Dosing Calculator for Type 2 Diabetes

Recruiting at 2 trial locations
HC
Overseen ByHou-Hsien Chiang, MD, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Washington
Must be taking: Insulin
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 3 JurisdictionsThis treatment is already approved in other countries

Trial Summary

Do I have to stop taking my current medications for the trial?

The trial protocol does not specify if you need to stop taking your current medications. However, since participants must be receiving insulin therapy prior to admission, it seems likely that you will continue your current insulin regimen.

What data supports the idea that Insulin Dosing Calculator for Type 2 Diabetes is an effective treatment?

The available research shows that insulin dosing calculators are effective in improving blood sugar control and patient safety. For example, one study found that integrating an insulin calculator into hospital systems helped improve patient care by ensuring timely insulin administration and better matching insulin doses with meals. Another study highlighted that these calculators are useful in managing insulin doses for patients after cardiac surgery, suggesting they help maintain stable blood sugar levels. Overall, these tools help reduce human error in insulin dosing, making them a reliable option for managing diabetes.12345

What safety data exists for the insulin dosing calculator for type 2 diabetes?

The safety data for insulin dosing calculators, including those used in different settings, suggest they improve patient safety and glycemic control. Studies have shown that these calculators, when integrated into electronic health records, help reduce errors in insulin dosing by providing a structured approach to dose calculation. They have been used effectively in both pediatric and adult hospital settings, with benefits such as improved patient education and workflow. However, challenges in implementation and integration have been noted, which require careful management to avoid potential pitfalls.12367

Is the Insulin Dosing Calculator for Type 2 Diabetes a promising treatment?

Yes, the Insulin Dosing Calculator for Type 2 Diabetes is a promising treatment. It helps doctors and patients manage insulin doses more accurately, reducing the chance of errors. This tool can improve patient care by making it easier to adjust insulin levels based on individual needs and food intake. It also integrates with electronic health records, making it convenient for hospital use.13489

What is the purpose of this trial?

The goal of this feasibility trial is to test whether a novel insulin dosing calculator can improve blood glucose management for patients with type 2 diabetes mellitus on hospital admission. The main questions it aims to answer are:* Whether using this calculator leads to no excessive hypoglycemia?* Whether using this calculator leads to a decrease of hyperglycemia?Participants will receive initial insulin doses by the calculator on hospital admission, and the rest of care will follow standard of care. Participants will be compared with patients in the UW observational cohort who received initial insulin doses by standard of care.

Research Team

HC

Hou-Hsien Chiang, MD, PhD

Principal Investigator

University of Washington

Eligibility Criteria

This trial is for patients admitted to the University of Washington Medical Centers who have type 2 or steroid-induced diabetes mellitus and were on insulin therapy before admission. It's not suitable for individuals outside these criteria.

Inclusion Criteria

Patients who are admitted to University of Washington Medical Centers
I have type 2 diabetes or diabetes caused by steroids.
I was on insulin therapy before being admitted.

Exclusion Criteria

Patients who report low appetite (25% or less) on admission or have a significantly decreased level of consciousness that they unlikely eat right after admission
I am currently in the ICU or obstetrics ward.
I have had severe diabetes complications like DKA or needed IV insulin.
See 3 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1 week

Treatment

Participants receive initial insulin doses by the calculator on hospital admission

48 hours
Inpatient hospital stay

Follow-up

Participants are monitored for safety and effectiveness after treatment

1 week

Treatment Details

Interventions

  • Initial insulin dosing using the calculator
Trial Overview The study is testing a new insulin dosing calculator against standard care in managing blood sugar levels upon hospital admission. The aim is to see if it reduces high blood sugar without causing too much low blood sugar.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Insulin dosing calculatorExperimental Treatment1 Intervention

Initial insulin dosing using the calculator is already approved in United States, European Union, Canada for the following indications:

πŸ‡ΊπŸ‡Έ
Approved in United States as Insulin dosing calculator for:
  • Type 2 diabetes mellitus
πŸ‡ͺπŸ‡Ί
Approved in European Union as Insulin dosing calculator for:
  • Type 2 diabetes mellitus
πŸ‡¨πŸ‡¦
Approved in Canada as Insulin dosing calculator for:
  • Type 2 diabetes mellitus

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Washington

Lead Sponsor

Trials
1,858
Recruited
2,023,000+

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborator

Trials
2,513
Recruited
4,366,000+

Findings from Research

The integration of an IV insulin calculator into the electronic health record in the cardiovascular intensive care unit (CVICU) improved glycemic control, with an increase in the percentage of blood sugar readings within the target range from 87.97% at baseline to around 91% at one to six months post-implementation.
The implementation also significantly reduced the incidence of severe hypoglycemia, with no blood sugar levels below 40 mg/dL recorded after the intervention, demonstrating enhanced safety in insulin management for critically ill patients.
Improving Hospital Glucometrics, Workflow, and Outcomes with a Computerized Intravenous Insulin Dose Calculator Built into the Electronic Health Record.Shelden, D., Ateya, M., Jensen, A., et al.[2021]
The implementation of insulin bolus calculators in inpatient care has been shown to enhance glycemic control and improve patient safety, highlighting their efficacy in managing diabetes in hospital settings.
The integration process revealed several challenges, such as timing of insulin administration and variations in bolus calculations, but also provided benefits in patient education and streamlined care, emphasizing the importance of a multidisciplinary approach in clinical settings.
Insulin Bolus Calculator: Lessons Learned from Institutional Experience.Nolt, VD., Araya, A., Ateya, MB., et al.[2021]
The implementation of a customized insulin bolus dose calculator for hospitalized pediatric patients did not increase the rates of hypoglycemia or severe hypoglycemia, indicating that it is a safe tool for managing insulin dosing.
User satisfaction with the insulin calculator tool was high, with physicians reporting slightly higher satisfaction than nurses, and a strong correlation was found between perceived quality of care improvement and overall satisfaction with the tool.
Insulin Bolus Calculator in a Pediatric Hospital. Safety and User Perceptions.Ateya, MB., Aiyagari, R., Moran, C., et al.[2018]

References

Improving Hospital Glucometrics, Workflow, and Outcomes with a Computerized Intravenous Insulin Dose Calculator Built into the Electronic Health Record. [2021]
Insulin Bolus Calculator: Lessons Learned from Institutional Experience. [2021]
Insulin Bolus Calculator in a Pediatric Hospital. Safety and User Perceptions. [2018]
Bolus calculator with nutrition database software, a new concept of prandial insulin programming for pump users. [2021]
Computerised insulin dosing calculators for the management of continuous insulin infusions after cardiac surgery: A systematic review and meta-analysis. [2018]
A simple computer program for insulin dose adjustment in diabetic patients. [2019]
Efficacy of a basal insulin dose management smartphone application for controlling fasting blood glucose in patients with type-2 diabetes mellitus: A single-centre, randomised clinical study. [2023]
Improving hyperglycemia in the hospital: outcomes of a nursing in-service to evaluate acceptance of a web-based insulin infusion calculator. [2021]
Glucose control in critical illness using a web-based insulin dose calculator. [2011]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of ServiceΒ·Privacy PolicyΒ·CookiesΒ·Security